ArticleSubstance use & addiction journal2026
Clinical Health Messaging for Perinatal Cannabis Use: Perspectives From Postpartum Individuals With Use During Early Pregnancy.
Article in Substance use & addiction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPerinatal cannabis use has become more common in the United States. However, the evidence that associates prenatal cannabis use with increased risk for adverse maternal and child health outcomes is also growing. Therefore, it is important to include perinatal cannabis risks in standard health warnings to perinatal patients. As health messaging that resonates with perinatal individuals who use cannabis regularly has not yet been identified, further testing is needed. Therefore, we sought to gain perspectives from postpartum individuals who used cannabis regularly in early pregnancy on perinatal cannabis use health messages.
methodsThis analysis used data from a larger qualitative study that recruited participants who were 4 to 12 months postpartum and self-reported daily or weekly cannabis use during early pregnancy (at ~8 weeks gestation) at prenatal care entry. We used a semi-structured interview guide to solicit participants' thoughts on 4 different messages containing perinatal cannabis use health information and warnings. We conducted interviews in April to May 2022. We used thematic analysis to identify key aspects of acceptable perinatal cannabis health messaging.
resultsSixteen participants provided feedback on the health messages. Participants were 21 to 33 years old, 6 to 11 months postpartum, and self-identified as black (n = 4), Hispanic (n = 4), and white (n = 8). None of the messages were wholly accepted across participants, but we identified 3 key aspects of acceptable health messaging for perinatal cannabis use: (1) use of neutral language and images, (2) inclusion of evidence for health risks, (3) present options or alternatives for cannabis use.
conclusionFindings provide evidence for perinatal cannabis use clinical health messaging that could resonate with perinatal patients who use cannabis and encourage open dialogue with their health care providers. Further research is needed to understand the actual impact of message exposure on perinatal cannabis use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.